Q702 for the Treatment of Patients With Hematologic Malignancies

Clinical trial NCT06712810 · RECRUITING

Trial details

NCT number: NCT06712810
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphatic System Neoplasm Histiocytic Sarcoma Malignant Histiocytosis Peripheral T-Cell Lymphoma, Not Otherwise Specified Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelomonocytic Leukemia Recurrent Follicular Lymphoma Recurrent Langerhans Cell Histiocytosis Recurrent Lymphoplasmacytic Lymphoma Recurrent Myelodysplastic Syndrome Recurrent Myelofibrosis

Start date: 2025-08-27
Primary completion: 2030-09-15
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.